GPR176 Is a Biomarker for Predicting Prognosis and Immune Infiltration in Stomach Adenocarcinoma
Immunotherapy based on immune checkpoint inhibitors (ICIs) is considered to be a promising treatment for stomach adenocarcinoma (STAD), but only a minority of patients benefit from it. It is believed that the poor therapeutic efficacy is attributed to the complex tumor immune microenvironment (TIM)...
Saved in:
Main Authors: | Lin Ni (Author), Shuming Chen (Author), Jianyong Liu (Author), He Li (Author), Hu Zhao (Author), Chunhua Zheng (Author), Yawei Zhang (Author), Hancong Huang (Author), Junjie Huang (Author), Bing Wang (Author), Chengzhi Lin (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exploring the Correlation Between GPR176, a Potential Target Gene of Gastric Cancer, and Immune Cell Infiltration
by: Gu X, et al.
Published: (2023) -
The Interactions Between GPR30 and the Major Biomarkers in Infiltrating Ductal Carcinoma of the Breast in an Asian Population
by: Wen-Hung Kuo, et al.
Published: (2007) -
The oncogenic roles of GPR176 in ovarian cancer: a molecular target for aggressiveness and gene therapy
by: Ning Yang, et al.
Published: (2024) -
Comprehensive analysis of the expression, prognostic, and immune infiltration for COL4s in stomach adenocarcinoma
by: Ying Xu, et al.
Published: (2024) -
Identification of GPD1L as a Potential Prognosis Biomarker and Associated with Immune Infiltrates in Lung Adenocarcinoma
by: Zhengyang Fan, et al.
Published: (2023)